Skip to main content
. 2021 Dec 16;10(24):5900. doi: 10.3390/jcm10245900

Table 3.

Echocardiographic, laboratory and clinical characteristics of COVID-19 patients at six months after initial hospital admission.

Myocardial Injury
(n = 43)
No Myocardial Injury
(n = 43)
p-Value
Echocardiographic characteristics
Interventricular septum wall thickness, mm * 10.0 (9.00–12.0) 9.00 (8.00–10.5) 0.002
Posterior wall thickness, mm * 10.0 (9.00–11.0) 8.00 (7.00–10.0) 0.002
LV telediastolic diameter, mm * 50.0 (45.0–55.5) 49.0 (45.0–53.0) 0.659
LV telesistolic diameter, mm * 30.0 (26.5–34.5) 30.0 (27.0–32.5) 0.274
LV end diastolic volume, mL * 91.0 (81.0–108) 85.0 (75.5–101) 0.111
LV end systolic volume, mL * 33.0 (26.0–46.0) 32.0 (25.0–41.5) 0.380
LV ejection fraction (Simpson’s biplane), % * 63.0 (60.0–67.5) 63.0 (58.0–67.8) 0.833
TAPSE, mm * 23.0 (21.0–25.0) 23.0 (20.2–24.8) 0.951
E/E’ratio * 8.00 (6.2–9.50) 8.00 (6.00–9.05) 0.303
PAP, mmHg * 34.0 (27.5–37.8) 29.0 (27.0–31.0) 0.021
Laboratory characteristics
Urea, mg/dL * 43.0 (35.0–52.0) 38.0 (32.5–44.6) 0.028
Creatinine, mg/dL * 1.01 (0.88–1.17) 0.91 (0.81–1.04) 0.041
Glomerular filtrate rate, mL/min/1.73 m2 ** 71.5 (24.3) 82.9 (20.4) 0.021
C-Reactive Protein, mg/dL * 0.18 (0.10–0.37) 0.13 (0.08–0.24) 0.236
NT-proBNP, pg/L * 119 (73.9–234) 71.3 (32.9–120) 0.001
Haemoglobin, g/dL ** 13.2 (1.40) 14.1 (1.29) 0.002
Leukocytes/µL×103 * 7020 (6170–7790) 6600 (5395–7670) 0.260
Lymphocytes/µL×103 * 1910 (1235–2205) 2080 (1710–2555) 0.062
D-Dimer, ng/mL * 295 (205–388) 230 (190–375) 0.137
Clinical characteristics
Chest pain 4.65% 2.33% 1.00
Palpitations 4.65% 0.00% 0.494
NYHA functional class I-II
NYHA functional class III-IV
93.0%
7.00%
97.7%
2.30%
0.407
Pulse oximetry * 98.0 (97.0–99.0) 97.0 (96.5–98.0) 0.098
Systolic blood pressure ** 141 (17.0) 136 (18.6) 0.194
Diastolic blood pressure ** 77.3 (11.7) 77.9 (13.2) 0.826

* Median (Inter-quartile range) ** Mean (standard deviation); LV, left ventricular; TAPSE, Tricuspid Annular Plane Systolic Excursion; PAP, pulmonary artery pressure; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; NYHA, New York Heart Association.